We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04895410
Brief Title: Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

First Submitted : May 19, 2021
First Submitted that Met QC Criteria : May 19, 2021
First Posted : May 20, 2021

Last Update Submitted that Met QC Criteria : July 6, 2022
Last Update Posted : July 8, 2022